603229.SH
奥翔药业
SSE · Healthcare · Biotechnology · CN
CNY 7.94
−1.98%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 19.47x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 18.74x
Trailing multiples
Trailing twelve months
- P/E TTM
- 50.49x
- PEG TTM
- —
- Price / book
- 2.85x
- Price / sales
- 8.14x
- Price / cash flow
- 53.71x
Enterprise value
- Enterprise value
- CNY 5.8B
- EV / sales
- 7.30x
- EV / EBITDA
- 27.09x
- EV / EBIT
- 52.45x
- Market cap
- CNY 6.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026